Navidea Biopharmaceutica (Israel) Financial Indicators Patterns

NAVB -- Israel Stock  

ILS 95.00  0.40  0.42%

Use fundamental data analysis to check out all available financial ratios of Navidea Biopharmaceutica to find out if markets are presently mispricing the entity. We found twenty-six available fundamentals for Navidea Biopharmaceutica which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Navidea Biopharmaceuticals fundamentals including its Gross Profit, Net Income, Cash per Share, as well as the relationship between EBITDA and Cash and Equivalents . Use Navidea Biopharmaceutica to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Navidea Biopharmaceutica to be traded at S99.75 in 30 days

Navidea Biopharmaceutica Company Summary

Navidea Biopharmaceutica competes with Bezeq Israel, Oil Refineries, Perrigo Company, Bank Leumi, and Israel Chemicals. Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio. Navidea Biopharmaceutica is traded on Tel Aviv Stock Exchange in Israel.

Navidea Biopharmaceutica Cash Flow from Operations vs Debt to Equity

Navidea Biopharmaceuticals is rated below average in cash flow from operations category among related companies. It is rated below average in debt to equity category among related companies .

Navidea Biopharmaceutica Market Fundamentals

 Quote95.00
 Change(%) 0.42%
 Change0.40 
 Open94.6
 Low92.7
 High96.0
 Volume198677.000
 ExchangeTLV

Distress Rating

Navidea Biopharmaceutica Financial Distress Probability

18% 
Chance of Financial Distress
Navidea Biopharmaceuticals has less than 18 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Navidea Biopharmaceutica

Compare Navidea Biopharmaceutica To Peers

Navidea Biopharmaceutica Opportunity Range

October 20, 2018 Opportunity Range

Please see also Stocks Correlation. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com